McAulay K - Search Results

1

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

Haque T, Wilkie GM, Jones MM, Higgins CD, Urquhart G, Wingate P, Burns D, McAulay K, Turner M, Bellamy C, Amlot PL, Kelly D, MacGilchrist A, Gandhi MK, Swerdlow AJ, Crawford DH. Haque T, et al. Among authors: mcaulay k. Blood. 2007 Aug 15;110(4):1123-31. doi: 10.1182/blood-2006-12-063008. Epub 2007 Apr 27. Blood. 2007. PMID: 17468341 Free article. Clinical Trial.

2

Epitope specificity and clonality of EBV-specific CTLs used to treat posttransplant lymphoproliferative disease.

McAulay KA, Haque T, Urquhart G, Bellamy C, Guiretti D, Crawford DH. McAulay KA, et al. J Immunol. 2009 Mar 15;182(6):3892-901. doi: 10.4049/jimmunol.0803572. J Immunol. 2009. PMID: 19265169

3

Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.

Vanhoutte VJ, McAulay KA, McCarrell E, Turner M, Crawford DH, Haque T. Vanhoutte VJ, et al. Immunology. 2009 Aug;127(4):577-86. doi: 10.1111/j.1365-2567.2008.03035.x. Immunology. 2009. PMID: 19604308 Free PMC article.

4

The immune response to primary EBV infection: a role for natural killer cells.

Williams H, McAulay K, Macsween KF, Gallacher NJ, Higgins CD, Harrison N, Swerdlow AJ, Crawford DH. Williams H, et al. Among authors: mcaulay k. Br J Haematol. 2005 Apr;129(2):266-74. doi: 10.1111/j.1365-2141.2005.05452.x. Br J Haematol. 2005. PMID: 15813855 Free article.

5

Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.

Wingate PJ, McAulay KA, Anthony IC, Crawford DH. Wingate PJ, et al. Among authors: mcaulay ka. J Med Virol. 2009 May;81(5):870-7. doi: 10.1002/jmv.21445. J Med Virol. 2009. PMID: 19319950

6

Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease.

McAulay KA, Haque T, Crawford DH. McAulay KA, et al. Br J Cancer. 2009 Sep 15;101(6):1019-27. doi: 10.1038/sj.bjc.6605278. Br J Cancer. 2009. PMID: 19738620 Free PMC article.

7

HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.

McAulay KA, Higgins CD, Macsween KF, Lake A, Jarrett RF, Robertson FL, Williams H, Crawford DH. McAulay KA, et al. J Clin Invest. 2007 Oct;117(10):3042-8. doi: 10.1172/JCI32377. J Clin Invest. 2007. PMID: 17909631 Free PMC article.

8

Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-up.

Haque T, McAulay KA, Kelly D, Crawford DH. Haque T, et al. Transplantation. 2010 Jul 15;90(1):93-4. doi: 10.1097/TP.0b013e3181d7c424. Transplantation. 2010. PMID: 20606564 No abstract available.

9

Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.

Haque T, Chaggar T, Schafers J, Atkinson C, McAulay KA, Crawford DH. Haque T, et al. J Med Virol. 2011 Feb;83(2):311-6. doi: 10.1002/jmv.21953. J Med Virol. 2011. PMID: 21181928

10

Sexual history and Epstein-Barr virus infection.

Crawford DH, Swerdlow AJ, Higgins C, McAulay K, Harrison N, Williams H, Britton K, Macsween KF. Crawford DH, et al. Among authors: mcaulay k. J Infect Dis. 2002 Sep 15;186(6):731-6. doi: 10.1086/342596. Epub 2002 Aug 20. J Infect Dis. 2002. PMID: 12198605 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters